title: Direct-to-Consumer Drug Advertising in Oncology Is Not Beneficial to Patients or Public Health.
authors.affiliation: Division of Hematology-Oncology and Cancer Center, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts.
authors.forename: Lowell E
authors.initials: LE
authors.lastname: Schnipper
authors.affiliation: Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.
authors.forename: Gregory A
authors.initials: GA
authors.lastname: Abel
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects / Q000191:economics / Q000627:therapeutic use; D000067088:Direct-to-Consumer Advertising; D004345:Drug Industry / Q000458:organization & administration; D006801:Humans; D033181:Information Dissemination; D009369:Neoplasms / Q000188:drug therapy*; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D000970:Antineoplastic Agents